80
Participants
Start Date
September 10, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2033
Secondary Cytoreductive Surgery
"Surgery will only be performed in patients assigned to the experimental arm of the study.~The goal of secondary cytoreductive surgery is to achieve complete tumor reduction by removing all visible residual tumors (Complete cytoreduction with no macroscopic residual disease), and this effort should be the top priority."
RECRUITING
National Cancer Center, Korea, Goyang-si
National Cancer Center, Korea
OTHER_GOV